Dallas Voice (Dallas, Tex.), Vol. 14, No. 46, Ed. 1 Friday, March 13, 1998 Page: 23 of 72
The following text was automatically extracted from the image on this page using optical character recognition software:
health and wellness in the Dallas/Fort
Worth area, she explained. Current
members include representatives from
the Foundation for Human
Understanding, Oak Lawn Community
Services, Winkle Consulting and
Research, Planned Parenthood of
Dallas and Northeast Texas, Cathedral
of Hope, Hands for Health
Chiropractic, Mobile Massage and the
YWCA Women's Resource Center. V
The fair takes place on March 21 from 9
a.m. to 5 p.m. at the Reverchon Recreation
Center, 3505 Maple Ave. Appointments for
mammograms or pap smears must be made
in advance. For appointments or other
information, contact Winkle at Metro 817-
Tulsa AIDS patient drops suit,
negotiates for unapproved drug
Associated Press U.S. Magistrate Sam Joyner ruled on
TULSA, Okla.—A lawyer represent- Jan. 15 that Cowan could not get an
ing a Sand Springs AIDS patient who injunction. He encouraged Davis to
has been suing the federal government continue pursuing FDA approval for
to obtain an unapproved drug says his his treatment.
client has declared a cease fire. U.S. Senior District Judge Thomas R.
Robert Cowan has dropped his law- Brett adopted Joyner's findings on sub-
suit, at least for now. stantive issues in the case on Feb. 18.
Cowan had sued the federal govern- But he said Cowan did have enough
ment, the U.S. Department of Health evidence to keep the case alive as a civil
and Human Services and the U.S. Food matter.
and Drug Administration in an attempt Jeff Nix, Cowan's attorney, said
to obtain a goat serum-derived anti- Friday that "we are in serious and pro-
body his doctor believes may help fight ductive" negotiations with the FDA to
his disease. But the FDA has argued obtain an emergency waiver that could
that Dr. Gary Davis of Tulsa has not yet allow Cowan to sample the antibody,
fulfilled the procedural steps necessary Nix said that in recent days, the FDA
for the antibody to be prescribed. has been "almost helpful" in its analy-
Cowan first took his battle to court in sis of the situation. He said he expects
late December. He said approved AIDS the FDA to make a decision sometime
treatments had not been effective for next week whether to allow Cowan to
him and he wanted to be allowed to try try the experimental drug.
Davis' antibody serum. Dropping the lawsuit was a gesture
He asked to be allowed to stop the of good faith, Nix said, but added that
FDA from interfering in his access to the matter could be refiled if the FDA
the treatment. doesn't rule in Cowan's favor. ▼
caps, t-shirts, subscriptions to Mamm
and Circles magazines, and more.
Admission to the health fair is free,
as is registration for the raffle drawings.
All services are offered for little or no
cost, Winkle said.
Organizers are asking, however, that
those attending, if possible, bring
unopened boxes of feminine products
which will be donated to area women's
shelters and street outreach projects.
Winkle said that all interested
women also are invited to attend the
next meeting of the Lesbian Health
Initiative, slated for Monday, March 16
at 7 p.m. at the Oak Lawn Public
Library. LHI is a group of women dedi-
cated to promoting physical and mental
Serving the Oak Lawn Community for over 21 Years
One Day Acuvue Available
Comprehensive Eye Exams
Computerized Corneal Mapping for
Contact Lens Fitting • Optical Shop
Ocular Disease • Refractive Surgery
QET FAST EFFECTIVE RELIEF FOR
3724 SPRING VALLEY RD. @ MARSH LN. ADDISON
PHYSICAL MEDICINE & REHABILITATION
Call for an Open Saturdays
Appointment. (372)488 9686
• Sports Injuries
• Muscle Strains or Spasms
• Shoulder Problems
• Back Problems
• Auto Accident/ On the Job Injury
• Injury Rehabilitation
• Body Fat Testing Available
General and Cosmetic Dentistry
Conveniently located at
4323 Lemmon Avenue
Call us at 214-521*5967
SUSTIVA efavirenz (formerly known as DMP 266)
EXPANDED ACCESS PROGRAM
FOR THE TREATMENT OF HIV
DuPont Pharma is pleased to announce its
Expanded Access Program for SUSTIVA™, a new investigational
non-nucleoside reverse transcriptase inhibitor used in combination
therapy for HIV disease. The program is open to HIV-positive
patients 13 years of age or older who are unable to tolerate, or
are failing to respond to, their current treatment and who meet
the entry criteria._
| EXPANDED INCLUSION CRITERIA ] now allow enrollment
of patients with CD„ <400 cells/mnv at any point in their history.
If you would like more information on participating in this
program, please contact your physician. Alternatively, contact
your local AIDS community-based organization, district public
health office, or call the toll-free number below.
Call the SUSTIVA
Expanded Access Program at 1-800-998-6854
Wilmington. DE 19880-0723 U.S.A.
SUSTIVA™ is a Trademark of The DuPont Merck Pharmaceutical Companv
MARCH 13, 1998
Here’s what’s next.
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Newspaper.
Vercher, Dennis. Dallas Voice (Dallas, Tex.), Vol. 14, No. 46, Ed. 1 Friday, March 13, 1998, newspaper, March 13, 1998; Dallas, Texas. (https://digital.library.unt.edu/ark:/67531/metapth616063/m1/23/: accessed April 18, 2019), University of North Texas Libraries, Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Special Collections.